Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Chemoradiotherapy in Stage IIIA NSCLC
NCT00979212Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Feb 2011
- Primary completion
- Dec 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in non-small cell lung cancer (NSCLC), sponsored by NRG Oncology. Started Feb 2011; status: completed.
02
Drugs
panitumumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00979212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979212.